Social ‘wanting’ dysfunction in autism: neurobiological underpinnings and treatment implications by Gregor Kohls et al.
Kohls et al. Journal of Neurodevelopmental Disorders 2012, 4:10
http://www.jneurodevdisorders.com/content/4/1/10REVIEW Open AccessSocial ‘wanting’ dysfunction in autism:
neurobiological underpinnings and
treatment implications
Gregor Kohls*, Coralie Chevallier, Vanessa Troiani and Robert T SchultzAbstract
Most behavioral training regimens in autism spectrum disorders (ASD) rely on reward-based reinforcement
strategies. Although proven to significantly increase both cognitive and social outcomes and successfully reduce
aberrant behaviors, this approach fails to benefit a substantial number of affected individuals. Given the enormous
amount of clinical and financial resources devoted to behavioral interventions, there is a surprisingly large gap in
our knowledge of the basic reward mechanisms of learning in ASD. Understanding the mechanisms for reward
responsiveness and reinforcement-based learning is urgently needed to better inform modifications that might
improve current treatments. The fundamental goal of this review is to present a fine-grained literature analysis of
reward function in ASD with reference to a validated neurobiological model of reward: the ‘wanting’/’liking’
framework. Despite some inconsistencies within the available literature, the evaluation across three converging sets
of neurobiological data (neuroimaging, electrophysiological recordings, and neurochemical measures) reveals good
evidence for disrupted reward-seeking tendencies in ASD, particularly in social contexts. This is most likely caused
by dysfunction of the dopaminergic–oxytocinergic ‘wanting’ circuitry, including the ventral striatum, amygdala, and
ventromedial prefrontal cortex. Such a conclusion is consistent with predictions derived from diagnostic criteria
concerning the core social phenotype of ASD, which emphasize difficulties with spontaneous self-initiated seeking
of social encounters (that is, social motivation). Existing studies suggest that social ‘wanting’ tendencies vary
considerably between individuals with ASD, and that the degree of social motivation is both malleable and
predictive of intervention response. Although the topic of reward responsiveness in ASD is very new, with much
research still needed, the current data clearly point towards problems with incentive-based motivation and learning,
with clear and important implications for treatment. Given the reliance of behavioral interventions on
reinforcement-based learning principles, we believe that a systematic focus on the integrity of the reward system in
ASD promises to yield many important clues, both to the underlying mechanisms causing ASD and to enhancing
the efficacy of existing and new interventions.
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Introduction
Autism is currently defined by impairments in social
interactions, communication and restricted interests and
behaviors [1]. The core social and communicative
impairments (which will probably be collapsed into one
category in the forthcoming fifth edition of the Diagnostic
and Statistical Manual of Mental Disorders) can be concep-
tualized as a set of related skill deficits (including social reci-
procity, social perception and memory, joint attention, and
perspective-taking). These deficits conspire to make it diffi-
cult for people with autism to develop and maintain social
relationships [2]. Considering the symptoms of autism
spectrum disorders (ASD) as developmental failure to ac-
quire adequate social-communication skills brings into
focus the learning processes that underlie ASD. Such skill-
based focus has concrete implications for treatment. Cur-
rently, there are no FDA-approved medications to treat the
core social and communicative skill impairments of ASD.
In fact, it is probably naive to expect that a medication is by
itself able to remediate a skill deficit, but it clearly might
have a role in potentiating or facilitating social skill learning.
At present, most interventions targeting social-
communicative skill defects and other behavioral problems
in ASD rely on the principles of applied behavior analysis
(ABA), especially operant techniques, where desired beha-
viors are reinforced using a variety of rewards (for ex-
ample, verbal praise, candy, or stickers). Accumulating
evidence from over 40 years of research indicates that
these reinforcement-based interventions significantly in-
crease both cognitive and social outcomes, and success-
fully reduce aberrant behaviors [3]. Although it is well
established and has proven efficacious at the group level,
this approach fails to benefit a substantial number of indi-
viduals on the autistic spectrum [4-6]. It is not yet under-
stood how and why behavioral approaches work well for
some people with ASD but not for others. As well as
factors such as lack of treatment fidelity, inadequate choice
of reinforcers, and absent generalization effects, reward
responsiveness might be a significant moderator of inter-
vention outcome in the context of behavior-analysis treat-
ment programs. Reward responsiveness most likely
mediates skill learning during these types of interventions
[4]. Thus, the variable treatment response rate of indivi-
duals with ASD might indicate that reward systems are
more efficient in those for whom behavioral interventions
are most effective than in those who profit only minimally
or not at all. Given the enormous amount of clinical and
financial resources devoted to reinforcement-based inter-
ventions, there is a surprisingly large gap in our knowledge
concerning the basic reward mechanisms in ASD. Under-
standing the mechanisms for reward-based learning is
urgently needed to better elucidate and inform modifica-
tions to the current standard of care.The aim of this paper was to review the biological
substrates of reward processing in ASD, including neu-
roimaging data, electrophysiological recordings, and
neurochemical measures. Because current ASD research
lacks a clear reference to any validated neurobiological
model of reward, we introduce a well-established frame-
work of reward responsiveness formulated by Berridge
and colleagues: the ‘wanting’/’liking’ model [7,8]. With
reference to this model, we summarize what is currently
known concerning the neural correlates underlying re-
ward responsiveness in ASD, with a special emphasis on
social reward versus other reward types. In this context, we
discuss how the available data may not only inform the
basic mechanisms of reward-based treatments in ASD, but
also variability in treatment response. Ultimately, such
knowledge could facilitate early diagnosis and future inter-
vention approaches with potentially greater treatment bene-
fits for a larger percentage of individuals with ASD. Finally,
we highlight several limitations in the current ASD reward
literature that probably contribute to discrepant study
findings and that should be resolved in future research.
A heuristic of reward responsiveness: the ‘wanting’/’liking’
model
The concepts of reward ‘wanting’ and reward ‘liking’
Most people associate reward with something pleasant
that they like, such as a piece of chocolate. However,
hedonic feelings are only one feature of reward. Research
has indeed shown that reward is not a unitary construct,
but is actually comprised of different components, which
can be dissociated both psychologically and neurobiolo-
gically [8]. One component is ‘liking’, which is related to
the pleasurable effect of reward consumption. The other
component is ‘wanting’ (also called ‘incentive salience’),
which corresponds to the motivational aspect of reward;
it is the anticipatory drive. Both reward components in-
clude conscious and unconscious levels of processing.
On a temporal dimension, the processing of reward can be
subdivided into two successive phases, with an appetitive
anticipation or ‘wanting’ period usually preceding a reward
consumption or ‘liking’ response (Figure 1). Typically,
rewards that are ‘liked’ are also ‘wanted’. Based on learning
experiences, previously neutral stimuli usually acquire
reward value either through the occurrence of hedonic sen-
sations of ‘liking’ an unconditioned stimulus (UCS) when
consuming it (for example, the actual taste of chocolate) or
through associations of a conditioned stimulus (CS) that
predicts a reward (for example, picture of a chocolate bar).
After learning, ‘wanting’ is easily triggered by encounters
with an incentive CS or with a reward itself (for example,
UCS). Incentive CS themselves become strongly salient,
and function as motivational ‘magnets’ attracting attention,
because they take on incentive properties similar to the
reward they predict. This can even turn a previously
Figure 1 A simplified view of the time course of reward processing and its underlying neural correlates (after Berridge and Kringelbach
[7]). Temporally, the processing of reward can be subdivided into two successive phases, with a ‘wanting’ period usually preceding a ‘liking’
response, each with a discrete neural basis. Although rewards that are ‘liked’ are typically also ‘wanted’, it seems that these two aspects of reward
are dissociable both psychologically and neurobiologically. Rewarding situations are characterized by an anticipation phase or the ‘wanting’ of a
reward, which often results in a phase of reward consumption or ‘liking’, with some rewards causing a peak level of subjective pleasantness (for
example, a lottery win, job promotion, encounter with an old friend, favorite meal or music, sexual orgasm, drug high). Many rewarding episodes
are followed by a period of satiation for the specific reward experienced. To our knowledge, there are currently no data available to suggest that
the ‘wanting’/’liking’ model would apply differently to social and non-social types of reward. However, some rewards lack satiation effects or result
in only short periods of satiation (for example, money). In general, physiological or drive states (for example, satiation, deprivation, stress, anxiety)
strongly modulate an individual’s responsiveness to reward. Both reward ‘wanting’ and reward ‘liking’ have been associated with discrete (and to
a specific extent with some overlapping) neural correlates. Whereas ‘wanting’ is mainly driven by phasic dopaminergic neural firing in the ventral
striatum (including the nucleus accumbens), ‘liking’ is largely influenced by the opioid system, and recruits the ventromedial prefrontal cortex
(vmPFC). As summarized in this paper, there is good evidence to suggest that reward ‘wanting’ is disrupted in ASD, particularly in the social
domain, whereas the available data for reward ‘liking’ are inconclusive (see below for details).
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cer for which people will work to obtain and ‘consume’
(for example, money). Humans possess a general intrinsic
motivation system, which regulates approach behaviors to-
wards pleasant stimuli and avoidance of threatening and
stressful events. The power of this ‘wanting’ system varies
from individual to individual, because of natural biological
differences in reward responsiveness and learned differences
in the value of different rewards.
Many rewarding episodes are followed by a period of
satiation for the specific reward that was consumed. To
our knowledge, there are no data available to suggest
that the ‘wanting’/’liking’ model would apply differently
to social and non-social types of reward. However, some
rewards lack satiation effects or result in only short periods
of satiation (for example, money). In general, physiological
or drive states (for example, satiation, deprivation) strongly
modulate an individual’s reward ‘wanting’ and ‘liking’
responses. For instance, food cues (for example, smell) are
very potent in eliciting desire for food when a person is
hungry, but are less salient when they have recently eaten a
meal. As noted above, both reward ‘wanting’ and ‘liking’
have been associated with some distinct (and to a specific
extent with some overlapping and interrelated) neural sub-
strates, which are reviewed next.The neurobiological substrates of ‘wanting’ versus ‘liking’
The neural circuit mediating reward-related behavior is a
complex network comprising, among others, the midbrain
(including the ventral tegmental area (VTA) and the sub-
stantia nigra (SN)), the amygdala, the ventral striatum (in-
cluding the nucleus accumbens (NAcc)), and the
ventromedial prefrontal cortex (including the medial orbito-
frontal cortex (OFC) and the ventral portion of the anterior
cingulate cortex (ACC)) [9] (Figure 2). Although several
brain structures contribute to the reward circuitry, the
central hub within this functional network is the ventral
striatum (VS) [10]. The VS receives major afferent input
from the OFC, the ACC, and the medial temporal lobe, in-
cluding the amygdala. In addition, strong reciprocal fiber
projections exist between the VS and midbrain regions.
Although mostly based on anatomical research in non-
human primates, recent developments in human brain
imaging, such as functional connectivity measures and
diffusion tensor imaging (DTI), confirm the complex
information transfer within this frontolimbic network
underlying reward processing [11].
Dopamine is the neurotransmitter predominately asso-
ciated with reward processing [12]. Most dopaminergic
neurons within the core reward circuitry, particularly in
the VS, show short bursts of phasic activation in
Figure 2 The neural circuitry of reward ‘wanting’ versus reward
‘liking’. The neural circuitry of reward ‘wanting’ comprises the
ventral striatum (VS; blue), while that for reward ‘liking’ comprises the
ventromedial prefrontal cortex, including the orbitofrontal cortex
(OFC) and the dorsal and ventral anterior cingulate cortex (dACC,
vACC) (green), which closely interacts with the amygdala
(AMY=orange) and the midbrain, including the ventral tegmental area
(VTA; purple). This complex network interfaces with motor-related areas
and other higher cognitive associative cortices (not shown here) to
translate basic reward information into appropriate goal-directed
action plans to achieve a desired reward.
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conditioned cues that signal a potential reward [13].
Although dopamine had long been thought to mediate ‘lik-
ing’, recent evidence indicates that dopamine is neither ne-
cessary nor sufficient for generating ‘liking’ responses, but
plays a more important role in the motivational component
(‘wanting’) of reward [8]. More specifically, it has been sug-
gested that the amount of phasic dopaminergic neuronal
firing encodes the incentive salience of appetitive environ-
mental stimuli, and that such firing typically precedes motor
behavior to seek out, approach, and consume a reward. Ani-
mal research using in vivo neurochemical methods indicates
that phasic dopamine signals in the VS, potentially influ-
enced by input from the midbrain, amygdala, and ventro-
medial prefrontal cortex (vmPFC), underlie non-social and
social reward-seeking behaviors, including eating, drinking,
reproduction, and other species-specific interactions [14].
By contrast, the hedonic effect of reward is primarily asso-
ciated with the opioid and endocannabinoid system [15,16].
Recent research aims to disentangle the spatiotemporal
localization of both these reward-related components in
the human brain using functional magnetic resonance
imaging (fMRI) [17], although early fMRI studies primarily
focused on money. Cued anticipation of monetary gains
has been consistently found to recruit the VS, including
the NAcc, with greater VS activity for more salient incen-
tives (for example, $1 versus $5; [18]). Similarly, animal
research suggests that cue-triggered VS activations pre-
cede reward consumption (for example, winning money)
and primarily reflect reward ‘wanting’ . This finding hasbeen replicated with other appetitive stimuli such as bio-
logical and social rewards [19,20], suggesting that the
VS, particularly the NAcc, functions as a general, modality-
independent mediator of reward ‘wanting’.
Reward ‘liking’, by contrast, has been primarily asso-
ciated with activations in vmPFC, particularly the medial
OFC and the ventral ACC [21]. Using prototypical fMRI
paradigms designed to investigate differential brain
responsiveness to reward consumption versus anticipa-
tion [18,22,23], the vmPFC has been repeatedly found to
be activated during the processing of pleasant outcomes,
including monetary and social rewards [24]. Insight into
the neural basis of reward ‘liking’ has also been gained
using pleasant-tasting food rewards. Diminished activity
in the OFC has been found after a specific food item has
been eaten to satiety, thereby decreasing its hedonic
value and subjective pleasantness [25,26]. More specific-
ally, a medial–lateral hedonic gradient has been indenti-
fied within the OFC, which tracks the reward value of
different reinforcers with regard to its valence [27]. Medial
OFC activity is related to the positive value of reinforcers
(for example, winning money), whereas the lateral OFC is
associated with evaluating the unpleasant aspects of
reinforcement (for example, losing money). This medial–
lateral gradient interacts with a second hedonic gradient
along the posterior–anterior axis, which represents sec-
ondary reinforcers (such as money), more anteriorly in the
OFC than primary reinforcers (such as odors, food, touch,
sexual pleasure, or drugs) [15,28,29].
The ‘wanting’/’liking’ circuitry also interfaces with
category-specific brain areas, allowing information
about the type of reward to influence the circuit [21];
for example, social rewards such as affirmative smiles
recruit reward structures and ‘social brain’ pathways
[30]. This complex network interacts closely with
motor-related areas and other higher cognitive associa-
tive cortices to translate basic reward information into
appropriate goal-directed action plans to achieve the
desired reward [9].
Relevance to research into autism spectrum disorders
Although the human fMRI literature is arguably more
complex than the simple VS (‘wanting’) versus vmPFC
(‘liking’) dichotomy described above [31], this framework
provides a useful heuristic model to evaluate reward
responsiveness in individuals with ASD. To date, little is
known about reward function in ASD, and conflicting
evidence comes from intervention programs versus
experimental research.
On the one hand, behavior analytic intervention pro-
grams, which place reward-based reinforcement at the
heart of their treatment system, have been repeatedly
found to improve socially appropriate behavior and cog-
nitive skills while diminishing dysfunctional activities
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reinforcers (food, tokens, sensory stimulation, toys, idio-
syncratic preferred objects, praise [33]), which act as key
levers for learning. For instance, when a positive reinforcer
follows a desired behavior, the future frequency of that
behavior is enhanced under similar conditions. By con-
trast, when positive punishment (for example, disapproval)
follows an undesired behavior, the future frequency of that
behavior is decreased under similar conditions. On the
other hand, evidence from behavioral experiments sug-
gests that individuals with ASD have diminished respon-
siveness to reward. Stimulus–reward association learning
has been repeatedly highlighted as an area of difficulty for
children with ASD [34,35], and variability in reward-
learning skills has been identified as an important pre-
dictor of social-communication abilities [36]. Interestingly,
the deficit in reward learning (and its link to social skills)
seems to persist through to adulthood, as evidenced by
impairments in the rapid formation of reward–stimulus
associations and its correlation with clinical symptoms of
social dysfunction [37-39].
Furthermore, both intervention research and behavioral
investigations have suggested that individuals with ASD
might be characterized by particularly low responsiveness
to social rewards such as facial expressions (for example,
smile), spoken language (for example, praise), and gestures
(for example, the thumbs-up gesture) [40,41]. In fact, in
behavioral treatment programs, young children with ASD
profit less from the use of social rewards than from non-
social reinforcers [42,43], and several experimental studies
have confirmed that, relative to typically developing
children (TDC), the performance of children with ASD is
only minimally affected by social reinforcement [44-47].
To date, the paradoxical finding of efficacious treatments
rooted in reinforcement strategies in combination with
weaker reward systems in ASD has received little attention
in the field. This highlights a gap in our understanding of
the underlying cognitive and biological processes that con-
tribute to treatment response. In particular, a potentially
important limitation of current experimental and interven-
tion research in ASD is that it tends to construe reward as
a unitary phenomenon, lacking a clear reference to any
validated neurobiological model of reward; however, a crit-
ical examination of reward function in ASD requires a
more fine-grained analytic approach. For instance, lower
responsiveness to social reward as evident at the behav-
ioral level could be the result of diminished ‘wanting’
or ‘liking’, or both. More specifically, reward ‘liking’
usually triggers and directs reward ‘wanting’ so that the
extent to which a reward is wanted typically depends on
the degree to which it has been liked [7]. However, in some
psychiatric disorders, such as addiction, schizophrenia, and
depression, ‘wanting’ and ‘liking’ can become uncoupled as
a result of circumscribed neurobiological dysfunctions [48].For example, a disruption in dopamine function might
cause diminished ‘wanting’ and approach behavior to obtain
a specific rewarding stimulus, even if the ‘liking’ response to
that particular reward is preserved. In the case of schizo-
phrenia, anhedonia (the reduced capacity to experience
pleasure or ‘liking’), has long been considered to be a car-
dinal symptom of patients with this disorder [49]. However,
recent studies using a range of pleasant stimuli, including
positive words, faces, sounds, film clips, erotic pictures, and
sweet drinks, have highlighted that the ability to experience
pleasure is generally intact in individuals with schizophre-
nia, whereas the capacity to pursue and achieve a pleasur-
able goal (that is, the ‘wanting’ component of reward), is
significantly disrupted [50]. Several authoritative reviews
thus concluded that anhedonia (diminished ‘liking’) is a less
prominent feature of schizophrenia than avolition
(diminished ‘wanting’) [49,51-53].
This example clearly illustrates that consulting the
‘wanting’/’liking’ model is particularly helpful to identify
which aspect of reward function is compromised or pre-
served in different psychopathologies. Such information
might facilitate efforts at early identification and could
have important implications for prevention and interven-
tion programs. In the case of ASD, an improved under-
standing of distinct reward functions and their respective
disruption may help to isolate discrete reward subpro-
cesses (‘wanting’ versus ‘liking’) and their associated bio-
logical substrates (VS versus vmPFC) as treatment
targets.
Given that there are currently no objective behavioral
markers of ‘liking’ and ‘wanting’, it is necessary to draw
on neurobiological measures. Three sets of data are
considered in this review: 1) functional neuroimaging
signals, 2) electrophysiological recordings, and 3) neuro-
chemical data. Several preliminary predictions can be
made with respect to the ‘wanting’/’liking’ model. If
‘wanting’ is compromised in ASD we would expect to
see 1) aberrant brain responses in the VS, 2) atypical
event-related brain potentials (ERPs) and EEG patterns
associated with the anticipatory aspect of reward, and
(3) disrupted dopamine function. On the other hand, if
‘liking’ is negatively affected, we would predict 1) aber-
rant brain activation in the vmPFC, 2) atypical ERP and
EEG responses related to reward outcome processing, and
3) disrupted opioid function. Considering the core social
phenotype of ASD (for example, ‘lack of spontaneous
seeking to share enjoyment, interests, or achievements with
other people’ [1]), it can be speculated that both ‘wanting’
and ‘liking’ of social reward is compromised in this dis-
order, with the most pronounced disruptions to be
expected for social reward ‘wanting’ (that is, social moti-
vation). In the following sections, we evaluate the extent to
which the proposed predictions are supported by the avail-
able data.
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Functional magnetic resonance imaging
Although the involvement of the mesocorticolimbic
reward circuitry in the psychopathology of ASD has been
discussed in the literature for many years [40,41,54-58],
only recently has research begun to systematically evaluate
potential malfunctions within this circuitry. In the following
section, we review the handful of studies that used fMRI to
compare the blood oxygen level-dependent (BOLD) signal
in response to different types of reward in children and
adults with ASD relative to typically developing controls.
There are complex sets of data reported across the different
studies, but in this paper, we focus exclusively on the VS
and the vmPFC as the neural substrates of reward ‘wanting
and ‘liking’ respectively. Further, because the amygdala
forms a unique microcircuitry with the VS and the vmPFC
to promote reward-seeking behaviors [59], and has been
repeatedly suggested to be dysfunctional in ASD [41], we
also review the amygdala-related findings in more detail.
The ventral striatum and reward ‘wanting’
The available data suggest that ‘wanting’ (the motivational
drive to achieve reward) is compromised in ASD. Four out
of five published fMRI studies reported diminished VS
activation in individuals with ASD compared with TDC
when processing either social or monetary reward versus
non-reward [30,60-62]. In two studies, Dichter and collea-
gues compared neural activation in samples of adults with
and without ASD during a delayed anticipation task with
two different reward contingencies. First, they tested brain
responses to money and typical autism-specific objects of
interest (for example, trains, cars, plastic bricks) and found
decreased VS activation in ASD during periods of money
anticipation and outcome, whereas VS activity was present
for typical autism-specific objects of interest [60]. In a fol-
low-up study applying the same paradigm but with a focus
on social (for example, faces) versus monetary reward,
adults with ASD again showed lower brain activation in
the VS during money anticipation, but did not reveal VS
hypoactivation for face rewards [61]. An early study by
Schmitz and colleagues applied a monetarily rewarded
sustained attention task to adults with and without ASD,
but did not report VS activation in either group [63].
Scott-Van Zeeland and colleagues [62] were the first to
compare BOLD responses to both monetary and social re-
ward (for example, smiling face combined with verbal
praise) in children with and without ASD performing an
implicit learning task. In this study, the ASD group dis-
played diminished activation in the VS for social reward,
but not for monetary reward. In addition, VS activation to
social reward predicted social capacities (as measured by
the Social Responsiveness Scale) within the TDC group,
but not the ASD group. Kohls et al. [30] also tested chil-
dren with and without ASD, and investigated BOLDresponses to social and monetary reward in the context of
an incentive go/no-go paradigm. Similar to the stimuli by
Scott-Van Zeeland and colleagues [62], approving faces that
were contingent on accurate task performance were used
as social reinforcers. Despite normal reward responsiveness
at the behavioral level, participants with ASD showed
hypoactivation in the VS under monetary reward condi-
tions that required an active response to obtain a reward.
Contrary to the authors’ predictions and to the results of
the previous study [62], significantly reduced VS responses
during social reward processing were not seen, but these
findings are consistent with results from Dichter et al. [61].
Taken together, blunted VS activity is a replicated
phenomenon in children and adults with ASD, and
might represent a neurobiological marker for diminished
incentive salience (‘wanting’) related to social and/or
monetary reward. Compromised ‘wanting’ possibly dis-
rupts the tendency in ASD to self-initiate goal-directed
actions to seek out specific environmental rewards (for
example, social incentives), whereas motivational tenden-
cies towards strongly preferred idiosyncratic rewards
seem to be preserved; typical autism-specific objects of
interest led to normal VS activation suggestive of intact
‘wanting’ for this type of incentive. However, it should be
acknowledged that the reviewed data provide a some-
what inconsistent picture about the specificity of VS dis-
ruption to social versus monetary reward. It is beyond
the scope of this paper to speculate upon the diverse
subject- and method-related factors that might have con-
tributed to these inconsistencies (for a thorough discus-
sion, see Kohls et al. [30]). Importantly, however,
although monetary reinforcers have predominantly been
operationalized and used as non-social stimuli, money is
imbued with social connotations and exerts a substantial
influence on pro-social behavior [64-66]. In this regard,
aberrant VS responses to monetary incentives would not
necessarily be at odds with the autism social phenotype.
In addition, different potencies of social reward have
been applied across studies, which could explain the dis-
crepant results with respect to this type of reward. A pic-
ture of a smiling face paired with verbal praise was used
as social reinforcement by Scott-Van Zeeland et al.,
whereas Dichter et al. and Kohls et al. chose static face
rewards without praise. It seems likely that the combin-
ation of facial rewards with praise may represent a stron-
ger social incentive with correspondingly greater reward
system responsiveness, primarily in TDC, making it
more probably that activation differences are detected
between individuals with and without ASD within the
VS. Future research should address these issues.
The ventromedial prefrontal cortex and reward ‘liking’
Regarding the vmPFC as the mediator of reward valuation
or ‘liking’, the available imaging data are rather mixed. For
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OFC), two studies reported stronger activation [62,63] and
two reported lower activation [30,61] in ASD compared
with TDC in response to monetary reward. In Schmitz’s
study [63], ventral ACC activity correlated positively with
social symptom severity (ADI-R), suggesting a possible
link between atypical reward consumption and social func-
tioning. Another study showed diminished activation in
the vmPFC under social reward conditions [30], which is
in contrast to data from Dichter et al. [61] and Scott-Van
Zeeland et al. [62]. Lastly, one investigation found greater
activation in the vmPFC in response to autism-specific
objects of interest in individuals with ASD relative to typical
control participants [60].
In summary, the current ASD imaging literature pre-
sents no clear pattern of results with respect to possible
differences from controls for reward consumption or
‘liking’. Interestingly, however, enhanced activation in
the vmPFC in response to high autism-interest objects
suggests that the hedonic value of such objects is greater
in individuals with ASD than in TDC. This idea is in line
with literature showing that certain classes of objects
and topics, which often constitute circumscribed interests,
are perceived as pleasurable by many affected individuals
[67], and the use of such items in behavior-analysis inter-
vention programs has been found to be therapeutically
effective [68,69]. However, on a day-to-day basis, these
strongly ‘liked’ circumscribed interests are likely to inter-
fere with social functioning.
The amygdala as a salience detector
The amygdala is thought to influence and amplify the
perception of emotionally and motivationally potent
stimuli at very early stages in their processing. It tracks
relevant positive and negative events in the environment
and contributes to appropriate adaptation of behavior
(for example, approach or avoidance reactions [70]).
Additionally, amygdala function is crucial for making an
association between a specific stimulus (for example, face
of an unknown person) and the affective experiences
intrinsically associated with this stimulus (for example,
pleasant social interaction with this person), linking ini-
tially neutral environmental stimuli with motivational
significance [71].
The amygdala has been repeatedly linked to the social
deficits present in ASD [41,56]. For instance, in an inter-
esting fMRI study, Grelotti and colleagues [72] found
weaker amygdala activation for faces than for cartoon
characters (for example, Digimon ‘Digital Monsters’) in
an autistic boy with a strong preoccupation with these
characters, whereas a matched typical control boy
showed the expected opposite neural activation pattern.
The strong amygdala engagement with the cartoon char-
acters seemed to reflect the exaggerated motivationalsalience tagged to this idiosyncratic interest relative to
faces. Put another way, decreased amygdala activation
for faces might reflect a lack of proper appetitive value
assigned to this class of stimuli [41,73].
The study by Dichter and colleagues [61] on reward
processing revealed hyperactivation in the amygdala in
adult participants with ASD while they were anticipating
social reward. This activation correlated positively with
social symptom severity (Autism Diagnostic Observation
Schedule-Generic ADOS-G). By contrast, Kohls and co-
authors [30] found hypoactivation in this brain area
under social reward conditions in children with the dis-
order. Both studies used very similar experimental task
designs with comparable reward contingencies. The
inconsistent finding might be due to the different ages
studied in the two papers, as other data suggest that
there could be an abnormal developmental trajectory of
amygdala reactivity to social incentives in ASD [74,75].
Systematic research is clearly needed to address this idea
and its implications for the development of aberrant so-
cially motivated behavior in ASD.Synopsis
In summary, the vmPFC–VS–amygdala circuitry seems
to be dysfunctional in ASD, and to form, at least par-
tially, the basis for atypical reward responsiveness in
individuals with ASD. Preliminary evidence indicates that
the motivational component of reward (the ‘wanting’)
might be particularly compromised in individuals with
ASD. This is reflected in blunted VS activity, which,
however, seems to be dependent on the incentive at stake
(that is, low versus high autism-interest rewards).
Dysfunction within the vmPFC–VS–amygdala system,
such as an insufficient communication between the
amygdala and/or the vmPFC to the VS, has been pro-
posed to underlie aberrant motivation to seek out detri-
mental substances at the expense of ‘natural’ rewards in
other psychopathologies (for example, addiction [76,77]).
It can therefore be hypothesized that an atypical pattern of
brain activity within this circuitry in individuals with ASD
may trigger strong seeking of salient, autism-specific
rewards at the cost of neglecting other essential environ-
mental rewards, including social rewards. In fact, several
recent imaging studies on resting-state functional con-
nectivity and DTI confirm disruptive neural activation
dynamics in ASD within the vmPFC–VS–amygdala cir-
cuitry [78-81]. These findings are also in line with the
idea of ASD as a neurofunctional disconnection syn-
drome [82-84], most likely mediated by complex genetic
factors (for example, synaptic cell adhesion plasticity
[85]), which affect efficient information transfer within
the mesocorticolimbic reward circuitry and may cause
aberrant motivation, that is, affect ‘wanting’ tendencies.
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Despite the fine spatial resolution of functional MRI, one
major limitation is its restricted temporal precision. For
instance, the BOLD signal in the VS evoked by reward-
predicting cues has been shown to rise at 2 seconds, to
peak between 4 and 6 seconds, and to fall back to base-
line after 10 to 12 seconds [86]. In contrast to the rela-
tive slowness of the brain’s BOLD response as measured
by fMRI, electrophysiological recordings such as electro-
encephalography (EEG) and ERP provide measures with
exquisite real-time temporal resolution on the scale of
milliseconds [87]. Thus, EEG and ERP might be specific-
ally suited to address the question about the extent to
which temporal phase of reward processing might be
compromised in ASD (reward anticipation/’wanting’
versus reward consumption/‘liking’). In the next section,
we summarize the current knowledge with regard to
electrophysiological correlates underlying reward respon-
siveness in individuals with ASD relative to controls.
Event-related brain potentials components related to
‘wanting’ and ‘liking’
Two ERP components are especially relevant to the
‘wanting’/’liking’ framework: the feedback-related nega-
tivity (FRN) and the P3 component. Although these two
ERP correlates are associated with well-described func-
tional roles in the cognitive neuroscience literature (FRN
with external reward monitoring; P3 with selective atten-
tion allocation), both have been repeatedly described as
indirect neural indices of reward responsiveness. The P3
and the FRN can be elicited by reward-predicting cues
and reward outcome. However, research and theory sug-
gests that the P3 is more closely related to reward-seeking
behaviors (‘wanting’) and the FRN to reward consumption
(‘liking’ or ’disliking’) [88,89].
The P3 is a positive ERP component with a maximum
deflection at parietocentral electrodes (for example, Pz),
whereas the FRN is a negative deflection, which has its
largest amplitudes at frontocentral sites (for example,
FCz). Each component peaks around 300 ms after the
onset of a critical stimulus. However, whereas the P3 has
been found to be sensitive to reward magnitude (that is,
larger amplitudes for high versus low reward) and reward
valence (that is, larger amplitudes for reward gain versus
loss), the FRN is modulated almost exclusively by reward
valence, with more negative waveforms in response to
non-reward outcome relative to reward gain [90]. More-
over, both components are influenced by an individual’s
task engagement, so that larger amplitudes result from
active goal-directed responding to achieve a reward com-
pared with the passive receipt of a reward [91]. Although
most normative studies have focused on the effect of
monetary reward on these components, more recently,
two reports showed that social rewards (for example,affirmative faces) elicited robust P3 and FRN responses
comparable with those evoked by monetary rewards
[92,93]. Additionally, different personality dimensions,
including reward dependence, seem to determine the ex-
tent to which both waveforms are modulated by reward
in the normal population [94,95].
According to the locus coeruleus norepinephrine (LC-
NE) P3 hypothesis, the P3 component reflects a short,
phasic signal of the widely distributed and synchronously
active LC-NE system, which closely interacts with the re-
ward circuitry (for example, vmPFC, amygdala) to evaluate
the salience of an incoming stimulus and, as a result, to
optimize active reward-seeking (‘wanting’) behaviors [89].
By contrast, the FRN can be understood as a general mani-
festation of a reward-monitoring system that recognizes dis-
crepancies of outcome expectancies during reward
consumption, for example, if a ‘liked’ reward is expected but
not delivered, it elicits a ‘disliking’ signal, which is reflected
in a negative ERP response. Such a mechanism enables an
individual to adjust their behavior adequately so that the re-
ward benefit can be maximized in the future. The vmPFC
(that is, ACC) and the striatum have both been suggested
as potential sources for the scalp-recorded FRN response
[96-98]; however, the involvement of the striatum is less
likely [99].
Feedback-related negativity, P3, and reward responsiveness
The field of ASD has a long and rich tradition of using
ERP measures to acquire detailed real-time information
about the dynamics and integrity of neural processes in
the brain of individuals with ASD [100]. However, re-
search has just started to evaluate the clinical utility of
the P3 and the FRN as potential markers for abnormal
reward responsiveness in ASD. In the following sections,
we present recent relevant findings and interpret them
in the framework of reward anticipation (’wanting’)
versus reward consumption (’liking’).
Groen and colleagues [101] investigated ERP responses
in a mildly impaired group of children with pervasive
developmental disorder not otherwise specified (PDD-
NOS) while they performed a reinforcement-based learn-
ing task with performance feedback (winning or losing
points). There was a robust P3 effect in response to feed-
back outcome. A P3 related to feedback anticipation was
not reported. The participants with PDD-NOS did not
differ from a TDC group in their outcome-evoked P3,
suggesting that feedback processing was intact in this pa-
tient group. Interestingly, however, during the anticipa-
tion of positive feedback, the PDD-NOS group displayed
an atypical stimulus-preceding negativity (SPN), an ERP
component that is thought to index reward anticipation,
similar to the P3 [102].
Larson and colleagues [103] used a gambling task to
specifically elicit the FRN and P3 in response to
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ASD. Reward anticipation was not assessed in this study.
Similar to the findings by Groen [101], the ERPs evoked
by reward outcome did not differ between the experi-
mental groups. The authors concluded that the neural
response to concrete, external feedback, that is, monet-
ary gain (‘liking’) and loss (‘disliking’), is intact in ASD,
reflected in normal FRN and P3 effects.
It should be noted that both Groen and Larson only used
one type of incentive in their studies, points and money re-
spectively, which leaves unclear the extent to which their
findings may also be relevant for other fundamental types
of appetitive stimuli such as social rewards. Kohls and col-
leagues [92] were the first to compare the effect of social
(that is, affirmative faces) and monetary incentives on ERP
responses in children with ASD versus TDC. They adopted
a cued go/no-go paradigm from the animal literature,
which has been widely used to assess reward anticipation
(initiated by cue signals) followed by goal-directed behavior
(for example, button press or inhibitory response) and a
potential rewarding outcome [104]. The authors focused
on the P3 as the ERP component of interest; the task de-
sign was not suited to evoke the FRN. Consistent with the
findings of Groen et al. [102] and Larson et al. [103], the
outcome-related P3 did not differentiate between ASD and
TDC participants. However, whereas the TDC group exhib-
ited an increased P3 in response to cues that signaled a po-
tential social or monetary reward, relative to non-reward,
the ASD group did not show this enhancement effect, and
even showed diminished P3 activity in response to cues that
triggered a phase of social reward anticipation. Moreover,
P3 activity elicited by incentive cues in both social and
monetary reward conditions correlated negatively with so-
cial symptom severity (ADOS-G), suggesting that children
with ASD who had stronger social deficits had weaker
modulation of the go-cue P3 when reward was at stake.
Based on the LC-NE P3 theory, the authors concluded that
the ERP data indicate an attenuated state of motivated at-
tention allocation, particularly towards signals that trigger
active reward-seeking (‘wanting’) behavior in individuals
with ASD [105].
Although it is premature to draw conclusions from only
three ERP reports, the evidence suggests that outcome-
related neural responses are less impaired in ASD (reflective
of relatively intact ‘liking’) than are brain potentials related
to the anticipatory period preceding reward consumption
(reflective of disrupted ‘wanting’), based on the incentives
used to date. This neural dysfunction involves both social
and non-social (for example, monetary) reward, with a
more pronounced deficit for social incentives.
Frontal alpha power asymmetries
The strength of reward approach tendencies can be
assessed across the age spectrum with active- andresting-state EEG by calculating hemispheric alpha
power asymmetries over the frontal cortex [106]. Indivi-
duals with greater frontal alpha activity on the left rela-
tive to the right hemisphere display more reward-seeking
behaviors than do individuals with greater activity on the
right side. The left vmPFC has been suggested as the
potential source for stronger left-sided alpha-band activity
[107]. Owing to the relatively limited spatial resolution of
EEG source localization techniques, it is not yet clear to
what extent other reward structures contribute to the
scalp-recorded alpha asymmetries. Because of its involve-
ment in reward ‘wanting’, one likely candidate is the dopa-
minergic VS [108,109].
With regard to autism, Sutton and colleagues [110]
were the first to investigate the relationship between
resting-state frontal alpha asymmetry and symptom se-
verity expression in ASD. Children with ASD who
showed left frontal EEG asymmetry were reported by
their parents to have fewer symptoms of social impair-
ment compared with children with right frontal asym-
metry; however, the former was accompanied by greater
levels of social anxiety and stress. These findings suggest
that children with ASD with left frontal asymmetry
might be more motivated to participate in social interac-
tions, possibly because of stronger ‘wanting’ tendencies.
A stronger inclination to seek out social interactions
may make the appearance of social impairments less
severe, resulting in reduced reports of symptoms,
whereas, the motivation to interact with others, coupled
with an underdeveloped behavioral repertoire to do so,
might result in heightened levels of social stress and anx-
iety [111]. Interestingly, the left asymmetry subgroup of
children with ASD has a great resemblance to the ‘ac-
tive-but-odd’ clinical subtype described by Wing and
Gould [112], whereas the right asymmetry group is more
consistent with the ‘passive’ or ‘aloof ’ subtypes [111].
Dawson and colleagues [113] first noted differences in
frontal alpha power in children with ASD classified as
‘active-but-odd’ versus ‘passive’. This was replicated re-
cently by Burnette and colleagues [114], who also found
that left frontal alpha asymmetry during resting state was
associated with later age of onset of ASD-specific symp-
toms based on parental report. This could indicate that
greater social interest (‘wanting’) may obscure social
symptom presentation in young children, resulting in
delayed identification.
In a first attempt to measure frontal alpha activity during
an active task, Kylliäinen and colleagues [115] recently
reported relatively greater left-sided frontal alpha activity
in TDC during viewing of faces with direct eye gaze,
reflective of motivational social approach [116], a pattern
that was absent in children with ASD. By contrast, no
group differences were detected in frontal alpha responses
to non-social control stimuli, such as automobiles. The
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direct eye contact may not be socially rewarding for chil-
dren with ASD, and thus, does not properly activate their
approach-related brain mechanisms. Interestingly, the data
did not support the assumption of greater aversion-related
physiological responses to direct eye gaze in ASD relative
to controls that have been made in previous reports
[117,118]. However, it should be noted that left frontal
alpha asymmetries have not been linked exclusively to
reward seeking in the social domain. Stronger responsive-
ness to monetary incentives also correlates with larger left
frontal alpha power in typical individuals [107], indicating
that EEG asymmetries reflect more general motivation
tendencies rather than specifically social ones. With regard
to ASD, further studies are warranted that assess, for in-
stance, frontal alpha activity in response to stimuli of high
autism-specific interest to test the extent to which an
exaggerated reward value of this type of stimuli contri-
butes to the presentation of the autism social phenotype
(for example, interference with socially motivated
approach behaviors).
Synopsis
In summary, electrophysiological studies in ASD show
atypical results related to the anticipatory (or ‘wanting’)
aspect of rewarding events, especially in the social do-
main, which may affect social orienting and approach.
However, the degree to which this impairment reflects
an intrinsic versus a learned process (or a combination
of both), and its specificity to social stimuli (versus, for
example, autism-specific objects of interest), is as yet un-
resolved. The literature suggests that stronger social
interest can potentially overshadow symptom expression
in young children with ASD, preventing early diagnosis.
Therefore, information about social motivation profiles
acquired through either behavioral and/or electrophysio-
logical measures (for example, frontal alpha asymmetry)
is crucial to facilitate efforts at early identification. More-
over, future inquiries will reveal the extent to which EEG
investigations can assist in determining which children
with ASD are likely to be treatment responders and
which might require special or modified treatment
efforts.
Neurotransmitters and neuropeptides
Although multiple reward-related neurotransmitters and
neuropeptides have been implicated as atypical in ASD,
we focus here on dopamine, opioid, and oxytocin (dys)
function, because of their potential effect on reward
‘wanting’ and ‘liking’ [56]. Dopamine and endogenous
opioids are well-known neurochemicals with circum-
scribed roles in motivational behavior such as reward-
seeking versus consumption, respectively [119], whereas
the peptide oxytocin has only recently becomeestablished as a facilitator of reward signaling and learning,
particularly in social contexts [120]. Thus, all three mole-
cules provide independent contributions to rewarding
effects, as described below.
The dopaminergic ‘wanting’ system
Dopamine mediates a variety of behaviors and functions,
including selective attention, learning, motor functioning,
hormone release, and goal-directed motivated behaviors
[121]. In this context, dopamine primarily encodes the in-
centive value (or the ‘wanting’) of reward. It is released in
response to contextual cues predictive of reward, initiating
a phase of reward anticipation and approach. Animal
research shows that dopamine antagonists or agonists
injected into the VTA and VS impair or facilitate, respect-
ively, reward approach behaviors, but not reward con-
sumption [119]. In humans, drug-induced activity in the
VS is linked to feelings of craving and ‘wanting’, but not to
feelings of euphoria or pleasure [122].
Dysfunction in the dopamine system in ASD has been
suggested, based on the beneficial effects of dopamine
receptor antagonists (for example, antipsychotic drugs
such as risperidone) in treating certain symptoms com-
monly exhibited by affected individuals, such as stereoty-
pies, aggression, hyperactivity, and self-injury [123].
Because such symptoms can be induced in animals by
increasing the dopamine level, it has been inferred that
ASD might be associated with mesocorticolimbic dopa-
minergic overactivity. However, conflicting results have
been found in studies measuring peripheral (for example,
blood, urine) or central (for example, cerebrospinal fluid
(CSF)) levels of dopamine and its metabolites, with some
studies reporting atypical dopamine turnover in patients
[121]. Evidence is also scarce and inconclusive with re-
gard to dopamine-related neuroimaging using positron
emission tomography (PET) or single photon emission
computed tomography (SPECT) in individuals with
ASD. For instance, Ernst and colleagues [124] found
reduced dopamine metabolism in the vmPFC, but not in
the VS, in children with ASD compared with controls.
However, follow-up studies could not confirm this early
finding, and reported either enhanced dopamine bind-
ings in the vmPFC [125], in the VS [126,127], or in both
brain areas [128], or did not find any abnormalities in
ASD [129]. It should be noted that urine, blood, CSF and
baseline PET/SPECT measurements usually assess stable,
tonic dopamine levels, whereas the beneficial effects of
antipsychotic drugs stem from blocking phasic dopamine
release, which only minimally contributes to these tonic
levels [130]. This raises the possibility of a dysfunction in
the phasic rather than the tonic dopamine metabolism in
ASD, which would be more consistent with the neuroi-
maging and electrophysiological findings of atypical re-
ward ‘wanting’. Indeed, reward-predicting signals and
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elicit brief, phasic, bursts of dopamine impulses, which last
less than 500 ms, and prompt reward anticipation [12]. Re-
search provides evidence that specific subpopulations of
dopaminergic cells within the VS respond differently de-
pending on reinforcer type. It has been shown that some
striatal cell groups encode primary reinforcers (for ex-
ample, water, food, sexual intercourse), whereas others are
thought to be ‘idle’ and modifiable through reward-based
learning (for example, drug conditioning [131]). The idea
that dopaminergic cell activity tracks different reward
types is intriguing, because it might offer a simplistic, al-
though plausible, explanation as to why some incentives
(for example, objects of circumscribed interest) induce
goal-directed approach behavior in individuals with ASD,
whereas others (for example, social reward) do not. Such
‘selective’ impairment could be thought of as genetically
driven [132,133], or acquired through aberrant learning
experiences, or both. Because single-cell recordings are
mostly limited to animal research, the use of mouse
models of ASD could be a fruitful approach to test the
merits of this idea [134].
The opioid ‘liking’ system
Behavioral effects of opiate administration include symp-
toms such as insensitivity to pain, social withdrawal,
motor hyperactivity, repetitive and stereotyped behaviors,
and hypersensitivity to sensory stimulation. This overlap
with ASD symptoms has led to the idea of an opioid dys-
function in autism [135-140]. Endogenous opioids (or
opiates, such as beta-endorphins or enkephalins) are
peptides that act as neuromodulators in the CNS and
dock at receptors activated by morphine, an alkaloid
extracted from opium, and related substances [141].
Thus, the euphoric and narcotic effects elicited by mor-
phine are thought to be shared by endogenous opioids pro-
duced by the body. A large body of evidence from animal
and human research suggests a role of endogenous opioids
in pleasant social and non-social behaviors, including sexual
activity, social interactions, play, grooming, and food intake.
In humans, endogenous opioids increase subjective feelings
of interpersonal warmth, euphoria, and calmness, but de-
crease incentive motivation. It has been proposed that en-
dogenous opioids induce pleasure and bring consummatory
behaviors to a satisfying conclusion [119,142,143]. This
‘liking’ role is emphasized by the fact that the vmPFC, a
brain area that is explicitly associated with reward ‘liking’,
contains a particularly high density of opioid receptors [15].
The data on the possible role of opioid dysfunction in
ASD has been conflicting, with opioid measurements
from urine, blood plasma and CSF being reported as
decreased, increased or normal [121]. Some authors
argue that there might be subtle alterations in opioid
functioning in ASD (for example, increased C-terminallydirected beta-endorphin protein immunoreactivity, but
normal N-terminally directed activity), whereas others
suggest that such aberrant opioid levels are not specific
to ASD [56]. Moreover, because of the putative role of
endogenous opioids in the regulation of social behavior,
several investigations have examined the effect of opioid
receptor antagonists (for example, naltrexone) on symp-
tom expression in ASD. Despite some modest effects on
maladaptive behaviors, for example, irritability, hyper-
activity, self-injury, most controlled studies suggest that
the efficacy of this treatment is limited, especially with
regard to the social symptoms of ASD [144]. Taken
together, there is no consistent evidence that atypical
opioid functioning is a determining factor for the core
phenotype of ASD. Considering that endogenous opioids
mediate the hedonic aspect of reward, this conclusion is
in line with the neurophysiological findings that reward
‘liking’ is less compromised than ‘wanting’ in affected
individuals.
The oxytocin system as neuromodulator of ‘wanting’ and
‘liking’
Several lines of inquiry suggest that social cognition and
behavior are regulated by a combination of dopamine,
opioids and the hormone oxytocin [145,146]. Oxytocin is
a nine amino-acid peptide, which is synthesized in the
paraventricular and supraoptic nucleus of the hypothal-
amus, and released into the bloodstream by the posterior
pituitary with wide distribution in the central nervous sys-
tem [147,148]. Oxytocin is best known for its contribution
to numerous social functions in humans and animals, in-
cluding social recognition, species-specific interactions,
attachment, and other pro-social behavior [120,149-151].
Cumulative evidence is consistent with the view that oxy-
tocin enhances the motivation for social interactions
through a complex functional system. This involves
increased social attention and memory and reduced social
stress and social anxiety, which in combination promote
the ability and willingness of an individual to repeatedly
take risks in approach, cooperative, and trusting behaviors
[152]. Oxytocin exerts its effects on social motivation
through a variety of neurochemicals among which dopa-
mine and opioids are key players. Both dopamine (‘wanting’)
and opioids (‘liking’) mediate social encounters and eventu-
ally the formation of pleasant social rewards and memories
associated with such occurrences. In turn, this increases the
likelihood of an individual to seek out these stimuli in the
future [119].
External contextual cues predictive of potential social
reward (for example, face or voice of the caregiver) serve
as incentive signals that elicit a dopamine-related antici-
patory phase of ‘wanting’. Oxytocin is thought to en-
hance the perceptual salience of such signals, which
facilitates their interpretation and influences affiliative
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oxytocin neurons in the hypothalamus may directly pro-
ject to the VS, activating dopamine release and influen-
cing locomotor behavior [153,154]. As the affiliative
person is reached, the exchange of reward (for example,
pleasant touch, approval) triggers opioid release, which
promotes a state of pleasure and ‘liking’. During this
consummatory phase of ‘liking’, oxytocin has the poten-
tial to increase opioid release in the brain by up to 300%
[155]. In fact, it has been shown that brain areas that are
innervated by dopamine and opioids including the VS,
the VTA and the prefrontal cortex, contain a high dens-
ity of oxytocin receptors, making these regions very
receptive to changes in central levels of oxytocin
[119,156]. Moreover, human imaging demonstrates that
intranasally administered oxytocin acts directly on brain
processes by modulating social and reward circuitries
[157-163]. As a result of the neurochemical interplay
between the oxytocin , dopamine, and opioid systems,
social encounters and contextual stimuli associated with
these encounters (for example, face of the caregiver) are
tagged with positive reward value, an essential prerequisite
for socially motivated approach behaviors (for example,
orienting towards the caregiver).
Evidence is emerging that the oxytocin system is altered
in ASD [164], which might be a contributing factor to
atypical reward functioning in affected individuals. Dawson
and colleagues [40], drawing upon the work of Insel and
colleagues [165], proposed a model suggesting that social
reward deficits in ASD could result from alterations in
oxytocin activity in the context of social interactions, which
negatively influence the dopaminergic reward system, and
prevent linking of social stimuli with their proper reward
value. In fact, two studies have found lower average levels
of blood plasma concentrations of oxytocin in individuals
with ASD relative to controls [166,167], a decrease that
could stem from inefficient or incomplete conversion of
oxytocin from its precursor prohormone [168,169].
Genetic associations between ASD and the oxytocin re-
ceptor gene, and with the closely related vasopressin
gene, have also been reported [170]. As discussed by
Insel et al. [165], abnormalities in the oxytocin neural
pathway could account for many features of ASD, in-
cluding early onset, predominance in males, genetic
loading, and neuroanatomical abnormalities. In fact,
postmortem brain analyses were found to have a specific
decrease in oxytocin mRNA in the temporal cortex in
ASD, which was associated with hypermethylation [171].
The reduced expression of oxytocin receptors in the
temporal lobe of persons with ASD is interesting in light
of extensive evidence suggesting that the temporal lobe,
including the amygdala, has a special role in social percep-
tual and reward processes [41,70]. The most promising
data suggestive of an oxytocin deficiency related to thedevelopment of ASD come from pioneering studies on the
therapeutic effects of intravenous and intranasal oxytocin
in individuals with this disorder. These initial studies
found that oxytocin , relative to placebo, reduces repetitive
stereotypic behaviors [172], improves the recognition and
memory of social–emotional information [173,174], and
increases cooperative behaviors, trust, and attention to
socially informative stimuli (for example, eyes) [166]. Con-
sidering the role of oxytocin within the ‘wanting’/’liking’
framework, the positive therapeutic effects on social func-
tioning in ASD may be partially mediated by enhanced so-
cially motivated attention and drive (‘wanting’) towards
important social encounters and affiliation (for example,
social stimuli or interactions [120,146]). The extent to
which this enhancement of social responsiveness is indeed
a direct consequence of oxytocin-induced dopamine in-
volvement remains to be determined [175,176]. Innovative
research is needed to elucidate the interaction between
oxytocin and dopamine as well as between oxytocin and
opioid systems to guide both theory (for example, neuro-
biological basis of social motivation deficits in ASD) and
specifically tailored therapeutic approaches for manipulating
the underlying neural circuitries (see also the Discussion
section).
Synopsis
In summary, whereas the opioid ‘liking’ system lacks
consistent evidence of involvement, both the dopamine-
mediated ‘wanting’ system and particularly the oxytocin
system are promising candidates for contribution to
atypical reward-related behaviors in ASD. Given the
close interaction between dopaminergic and oxytocin
mechanisms in driving socially motivated behaviors, any
imbalance within the physiological interplay of these two
mechanisms has the potential to disrupt social ‘wanting’
tendencies such as seeking out of social activities or friend-
ships. Based on the evidence reviewed in this section, it
can be hypothesized that the administration of oxytocin as
a pharmacological adjunct to social reinforcement learning
procedures may help tag social stimuli with incentive value
by stimulating social brain and reward circuitries, and thus
potentiating social reward-based ‘wanting’ [177]. We elab-
orate on this idea below.
Discussion
The fundamental aim of this paper was to present a
fine-grained analysis of reward responsiveness in ASD
embedded in the ‘wanting’/’liking’ framework [7,8,178].
The evaluation across three converging sets of neurobio-
logical data, including functional neuroimaging responses,
electrophysiological recordings, and neurochemical mea-
sures, revealed disrupted social reward ‘wanting’ capacities
in individuals with ASD, most likely caused by dysfunction
of the dopaminergic–oxytocinergic ‘wanting’ circuitry,
Kohls et al. Journal of Neurodevelopmental Disorders 2012, 4:10 Page 13 of 20
http://www.jneurodevdisorders.com/content/4/1/10including the VS, amygdala, and ventromedial prefrontal
cortex. This is in line with predictions derived from
current (and forthcoming) diagnostic criteria concerning
the core social phenotype of ASD, which emphasize diffi-
culties with spontaneous self-initiated seeking of social
encounters [1]. Reduced social–motivational drive and
interest has also been found in infants at genetic risk for
ASD, who are later diagnosed with the disorder [179-181].
By contrast, empirical evidence for compromised reward
‘liking’, including social reward, is inconclusive, and at this
point, not strongly supported by data on hand [54]. How-
ever, the literature is still very new, with few studies, each
of which varies in what could be important details of their
methodology. Hence, it would be premature to try to draw
firm conclusions. Much more research is needed to eluci-
date the nuances (for example, developmental trajectories,
heterogeneity) of reward ‘wanting’ versus ‘liking’ in ASD.
Moreover, what still needs to be determined empirically is
the extent to which a deficient dopaminergic–oxytocinergic
‘wanting’ circuitry in fact affects motivational actions, social
functioning and development in affected individuals.
Social motivation theory of ASD
It should be acknowledged that disrupted social engage-
ment certainly falls short of explaining the full picture of
the ASD phenotype, including non-social weaknesses
and strengths [2]. However, on the basis of the evidence
summarized in this paper and by others [2,40,41,54,56],
it seems to be crucial to elucidate the brain–behavior
underpinnings of aberrant social motivation, a core deficit
in ASD, and its diversity among affected individuals. Such
knowledge should advance our understanding of the etio-
logical and phenotypic complexities of the autism
spectrum, but may also lead to an understanding of the
unique risk and protective factors that can be specifically
targeted by intervention and prevention researchers [182].
This will help create tailored treatment programs that can
optimize functional outcome and, thus positively influence
the developmental course of an affected individual or an
individual with a genetic risk for the disorder.
By integrating behavioral observations and biological
findings, the social motivation theory of ASD posits that
ASD can be construed as an extreme case of reduced social
interest. This reduction fundamentally alters how indivi-
duals with ASD attend to and interact with the world,
depriving them of crucial social perceptual and social cogni-
tive learning opportunities [2,4,40,41,54,183]). The theory
assumes that the social motivation impairment is attribut-
able, at least partially, to dysfunction of the dopaminergic–
oxytocinergic vmPFC–VS–amygdala brain network [2,40].
Consistent with the expression of the core social phenotype
[1] and in line with evidence reviewed in this paper, it is
most likely that the lack of social-seeking tendencies in indi-
viduals with ASD is caused by an inability of the ‘wanting’circuit to activate motivational behaviors, particularly in so-
cial contexts. We extend this idea by hypothesizing that
diminished activation associated with social ‘wanting’ may
additionally be affected by exaggerated brain receptivity for
non-social objects of high autism salience [60,72,184]. Such
circumscribed stimuli may indeed have greater than normal
incentive valence for individuals with ASD (for yet unclear
reasons), and thus potentially further absorb resources
typically dedicated to social interests and attention [184].
An alternative, but not mutually exclusive explanation
is that social anxiety, as opposed to diminished social
motivation, contributes to social avoidance behaviors in
ASD [185]. The unpredictable nature inherent in social
encounters might be particularly challenging for indivi-
duals with ASD [186], and could promote symptoms of
anxiety and withdrawal. In fact, unpredictability has
recently been reported to elicit anxiety-like behavior in
humans and mice, reflected in amygdala involvement at
the brain level [70,187]. Further inquiries are clearly
needed to clarify the extent to which social anxiety, rela-
tive to low social motivation, is implicated in the core
social phenotype of ASD.
Implications for treatment
A weak social ‘wanting’ circuitry suggests that particularly
strong social cues, in combination with other strategies to
boost attention and engagement [2], might be necessary
for individuals with ASD to help them establish motiv-
ational salience and initiate desired behaviors [4,42]. The
initial behavioral modification programs attempted to
create responsiveness to social stimuli through operant con-
ditioning using already powerful reinforcers (for example,
food [43,188,189]), but this approach only showed limited
generalization effects to daily social function [42]. Later
programs focusing on the functional (that is, contextual)
analysis of problem behaviors were more successful in
addressing core deficits [3,5,6,32,42,190-196]. Not surpris-
ingly, diminished motivational tendencies, in particular
reduced self-initiated social encounters, have been identified
as a pivotal area of intervention in ASD [42,197]. The litera-
ture reviewed in this paper clearly supports this approach
by highlighting that impaired social motivation is most
likely caused by functional disruptions in the ‘wanting’
circuitry.
A number of intervention-related factors that promote
successful treatment outcome in ASD, in terms of social
and cognitive gains, have been defined (for example, ini-
tiation of intervention before the age of 4 years, intense
delivery of h more than 20 hours/week for at least 2 years,
incorporation of reinforcement principles; [182]). How-
ever, the percentage of affected children who actually
profit from behavioral treatment, let alone reach optimal
outcome (recovery), differs widely between studies, ranging
from 3% to 50% [4]. Most recently, child characteristics that
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described. Besides intellectual and language abilities, several
studies suggest that individual differences in the degree of
social motivation tendency are associated with treatment
efficacy [182]. Young children with ASD who display
stronger social approach (‘wanting’) and fewer avoidance
behaviors at treatment onset are more responsive to early
intensive behavioral interventions than are passive and
avoidant children [198-202]. It seems that children with
greater inherent social interest engage more actively and
constructively in the intervention procedures, which
results in greater benefits. However, Koegel and colleagues
[198] found that children with few social-seeking attempts
and initially poor treatment outcome were able to learn
social self-initiations (for example, seeking adults for help
and attention), which then led to favorable intervention
effects (for example, having best friends, going to birthday
parties and sleepovers, talking to friends on the phone).
Similar findings were reported by Kasari et al. [203]. Taken
together, impaired social motivation, a core deficit with
considerable variation among individuals with ASD, is
malleable, and its successful treatment contributes to better
functional outcome.
If our conclusion about a biobehavioral imbalance of
diminished social ‘wanting’ and excessive seeking of ASD-
specific stimuli is correct, it argues in favor of capitalizing
on the latter to improve the former. This idea is not new,
as there have been several small-scale behavioral interven-
tion studies reporting that the use of child-preferred
objects and activities to promote social initiations indeed
increases this type of behavior in ASD [42,204-206].
Because many children with ASD show circumscribed
interests in mechanical systems [207], we foresee that new
technologies, including computers (for example, video
games), internet platforms, or robots, also have the po-
tential, if used thoughtfully, to become therapeutically
meaningful [208,209].
Moreover, given the possible involvement of the
dopaminergic–oxytocinergic circuitry in social motivation
deficits, oxytocin pharmacotherapy seems to be a promising
treatment approach for ASD [120]. Intriguingly, animal
models show that oxytocin can exert therapeutic effects via
binding to the vasopressin receptor V1a in the absence of
functional oxytocin receptors [210]. Therefore, adminis-
tering oxytocin (for example, in the form of a nasal
spray), or other substances that enhance central oxytocin
turnover might be effective in ASD even in the presence of
a disrupted oxytocin system [164]. However, most recent
literature reviews conclude that oxytocin pharmacotherapy
alone will probably have only limited long-term beneficial
effects on pro-social functioning [120,149,152,164]. Com-
bining oxytocin with a structured social-skills training
regimen, as part of ABA [42] or computerized gaming, has
the potential to be a more effective treatment for socialmotivation impairments and other skill deficits in ASD
[177,211]. Ultimately, it is hoped that such combination
treatments will result in optimal outcome for a larger
percentage of individuals with ASD than traditional
behavior-only approaches.
Obstacles and recommendations for future research
One significant obstacle in the field concerns the tremen-
dous phenotypic heterogeneity of ASD, with important con-
sequences for intervention outcome. There is shockingly
little research on that topic to date. Besides pre-treatment
variables such as the degree of social motivation capacities,
other subject characteristics have been described that can
potentially impair reward sensitivity, and thus may con-
tribute to treatment failure in ASD. For instance, co-mor-
bid traits, such as depression, anxiety, or inattention/
hyperactivity, are often associated with ASD [212], and are
known to affect general reward processing [213,214] and
intervention response [215]. Moreover, research indicates
that sleep deficit, a problem commonly exhibited by
individuals with ASD [216], alters reward receptivity,
particularly to social rewards [217-219]. Lastly, individual
differences in temperament and achievement/intrinsic mo-
tivation tendencies have been documented in ASD
[220,221], and can result in differential responsiveness to
reward [222,223]. Taken together, these findings
emphasize the need for rigorous assessments and optimal
management of such factors to increase the likelihood of
optimal outcome. However, laboratory-based measures
that accurately quantify reward responsiveness and mo-
tivational tendencies in ASD are lacking, and have yet to
be developed. Additionally, a goal for future research is
to identify neurobiological ‘traits’ for example, [224] and
genetic moderators [225,226] that are predictive of treat-
ment response. This will allow determination of which
treatment option works well for a specific subset of indi-
viduals with ASD but not for others.
A second obstacle relates to methodological shortcomings
in experimental research on reward responsiveness. For in-
stance, there is a lack of research into biological rewards
such as food items, despite these being a most commonly
used reinforcer during intervention. Furthermore, physio-
logical or drive states have been neglected, although inter-
vention researchers have shown that individuals with ASD
respond at higher rates to social rewards under conditions
of social deprivation than during social satiation, for ex-
ample [227]. Lastly, many reward stimuli used in experi-
mental tasks lack ecological validity. For instance, static
images of smiling people and coins have been used as social
and monetary rewards respectively [61,62,92]. Taken to-
gether, the field needs an innovative line of experimental
research that systematically assesses responsiveness to
different types of treatment-relevant reinforcers under
different physiological states at both the behavioral and
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stimulus sets and experimental paradigms are necessary to
fully understand the extent to which there is any domain
specificity to the reward dysfunction in ASD, which would
be most consistent with the core autism phenotype. Ultim-
ately, enhanced characterization of these processes will
contribute to our understanding of the biobehavioral het-
erogeneity of ASD and allow for the development of
better, more personalized treatments.Conclusion
The intent of this review was to spark interest in this
promising area of research and to move discussion of so-
cial motivation and reward-based learning more into the
mainstream of the autism research community. Given
the prominent role that behavioral interventions play in
the lives of families affected by ASD, and that these
interventions can be ineffective in a large percentage of
cases, its seems imperative that new research agendas in-
clude the study of reward mechanisms, supported by
efforts of both cognitive science and cognitive neuroscience.
Firm conclusions about the relative importance of ‘wanting’
and ‘liking’ components of reward in ASD are not yet pos-
sible, owing to the paucity of studies. However, the data
published to date indicate the importance of social motiv-
ation (‘wanting’) and of the forces that propel social striving
as crucial to understanding and treating autism. We expect
that the next decade of systematic research will elucidate
with greater detail the basis of these deficits, and that this
knowledge will be translated into more effective treatments.
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